Impact of Art Therapy on Brain Connectivity in Recent Post-Stroke Aphasia (ART-CONNECT)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03820843 |
Recruitment Status :
Not yet recruiting
First Posted : January 29, 2019
Last Update Posted : January 13, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Ischemic or Hemorrhagic Stroke | Other: Art therapy and standard orthophonic rehabilitation | Not Applicable |
The investigators will evaluate, at inclusion and at 6 weeks, the reorganization of functional and structural brain connectivity maps before and after rehabilitation of aphasia with art therapy and standard orthophonic rehabilitation versus a control group that received only standard orthophonic rehabilitation.
The investigators will include all consecutive patients with recent ischemic or hemorrhagic stroke with unilateral lesion(s) of the parieto-temporal left junction present on the Diffusion MRI (DWI) performed in acute phase at 24-48h.
All patients will undergo 2 MRI with tensor diffusion sequences (structural connectivity) and fMRI (functional magnetic resonance imaging) resting state sequences (functional connectivity) at inclusion and 6 weeks after rehabilitation with or without art therapy.
The investigators aimed to demonstrate that early activation of the right hemisphere related to the practice of the visual arts could facilitate the recovery of language in later strokes completely disrupting the language areas of the left hemisphere.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 40 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | The investigators will evaluate the reorganization of functional and structural brain connectivity maps before and after rehabilitation of aphasia with art therapy and standard orthophonic rehabilitation versus a control group that received only standard orthophonic rehabilitation. |
Masking: | Double (Investigator, Outcomes Assessor) |
Masking Description: | Single-blind: only the art therapist knows the randomization arm. The investigators involved in the outcomes assessement, will remain blinded with regard to the randomized treatment assignments |
Primary Purpose: | Treatment |
Official Title: | Impact of Art Therapy on Brain Connectivity in Recent Post-Stroke Aphasia (ART-CONNECT) |
Estimated Study Start Date : | February 1, 2020 |
Estimated Primary Completion Date : | February 15, 2021 |
Estimated Study Completion Date : | February 15, 2021 |

Arm | Intervention/treatment |
---|---|
Experimental: Art therapy
Art therapy and standard orthophonic rehabilitation
|
Other: Art therapy and standard orthophonic rehabilitation
In addition to standard orthophonic rehabilitation, the patient will receive 12 sessions of art therapy |
No Intervention: Control group
Only standard orthophonic rehabilitation
|
- change from baseline measurement of white substance bundles volumes for structural connectivity at 6 weeks [ Time Frame: from inclusion at 6 weeks ]
- change from baseline measurement of synchrony amplitude of slow fluctuations for functional Connectivity at 6 weeks [ Time Frame: from inclusion at 6 weeks ]
- change from baseline Aphasia at 6 weeks [ Time Frame: from inclusion at 6 weeks ]The BDAE (Boston Diagnostic Aphasia Examination) score ranges from 0 to 5, with higher values indicating more severe impairment
- change from baseline Aphasia at 6 weeks [ Time Frame: from inclusion at 6 weeks ]The ART (Aphasia Rapid Test) score ranges from 0 to 26, with higher values indicating more severe impairment
- change from baseline Anxiety and depression at 6 weeks [ Time Frame: from inclusion and at 6 weeks ]The HADS (Hospital Anxiety and Depression Scale) scores ranges from 0 to 21 for both anxiety and depression scores, with higher values indicating more severe impairment
- change from baseline Quality of life self-assessment at 6 weeks [ Time Frame: from inclusion at 6 weeks ]Visual Analogic scale of patient quality of life is a 0% to 100% scale, with 100 indicating the best health status
- Satisfaction self-assessment at 6 weeks [ Time Frame: at 6 weeks only ]visual analogic scale of patient satisfaction is a 0 to 10 scale, with higher values indicating better satisfaction

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with recent ischemic or haemorrhagic stroke with unilateral lesion (s) of the parieto-temporal left junction present on the Diffusion MRI (DWI) performed in acute phase at 24-48h
- Post stroke delay of 15 days to 2 months
- Existence of moderate to severe phasic disorders on Aphasia Rapid Test score (ART, score> 6, scale of 26 items)
- Patient able to read and understand French
- Rightful
- Normal and corrected vision and hearing
- Absence of pre-existing degenerative neurological disorder
- Patient having signed his consent
- Age ≥ 18 years
Exclusion Criteria:
- Patients with contraindications to MRI or claustrophobic
- Patients under legal protection
- Patients with behavioral disorders or disabling neurovisual disorders making participation in art therapy impossible
- Severe motor deficiency (hemiplegia) on the segmental force scale
- Mute patients, illiterate patients
- Patients leaving the neurological SSR department prematurely
- Patients not affiliated to a social security scheme
- Pregnant or lactating women.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03820843
Contact: Ahmed Bacha | 0142161677 | ahmed.bacha@aphp.fr | |
Contact: Anne Bissery | 0142162432 | anne.bissery@aphp.fr |
Principal Investigator: | Sophie Dupont | Assistance Publique - Hôpitaux de Paris |
Responsible Party: | Assistance Publique - Hôpitaux de Paris |
ClinicalTrials.gov Identifier: | NCT03820843 |
Other Study ID Numbers: |
APHP180312 N° IDRCB: 2018-A02462-53 ( Other Identifier: ANSM ) |
First Posted: | January 29, 2019 Key Record Dates |
Last Update Posted: | January 13, 2020 |
Last Verified: | January 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
brain connectivity aphasia art therapy rehabilitation |
Stroke Aphasia Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases Vascular Diseases |
Cardiovascular Diseases Speech Disorders Language Disorders Communication Disorders Neurobehavioral Manifestations Neurologic Manifestations |